Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Systematic Review

Published on 20 Sep 2022

COVID-19 and the risk of CNS demyelinating diseases: A systematic review

in Multiple Sclerosis and Neuroimmunology

Itay Lotan
Shuhei Nishiyama
Giovanna S. Manzano
Melissa Lydston
Michael Levy

Frontiers in Neurology

doi 10.3389/fneur.2022.970383

7,808 views
19 citations

Original Research

Published on 16 Sep 2022

Optical coherence tomography assessment of axonal and neuronal damage of the retina in patients with familial and sporadic multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Monika Grudziecka Pyrek
Krzysztof Selmaj

Frontiers in Neurology

doi 10.3389/fneur.2022.953188

1,781 views
2 citations

Original Research

Published on 16 Sep 2022

Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder

in Multiple Sclerosis and Neuroimmunology

Lingyao Kong
Yanlin Lang
Xiaofei Wang
Jiancheng Wang
Hongxi Chen
Ziyan Shi
Hongyu Zhou

Frontiers in Neurology

doi 10.3389/fneur.2022.958441

2,907 views
4 citations

Original Research

Published on 15 Sep 2022

Mendelian randomization analysis of the causal association of bone mineral density and fracture with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Yu Yao
Feng Gao
Yanni Wu
Xin Zhang
Jun Xu
Haiyang Du
Xintao Wang

Frontiers in Neurology

doi 10.3389/fneur.2022.993150

3,697 views
5 citations

Original Research

Published on 15 Sep 2022

Clinical characteristics and prognosis of anti-γ-aminobutyric acid-B receptor encephalitis: A single-center, longitudinal study in China

in Multiple Sclerosis and Neuroimmunology

Xuedan Feng
Yujing Zhang
Yu Gao
Jing Zhang
Shasha Yu
Jing Lv
Yu Zu
Lin Wang
Xiangbo Wang

Frontiers in Neurology

doi 10.3389/fneur.2022.949843

2,513 views
9 citations

Case Report

Published on 15 Sep 2022

IgG4-related hypertrophic pachymeningitis with ANCA-positivity: A case series report and literature review

in Multiple Sclerosis and Neuroimmunology

Cheng Xia
Ping Li

Frontiers in Neurology

doi 10.3389/fneur.2022.986694

3,981 views
1 citation

Original Research

Published on 12 Sep 2022

Neuromyelitis optica spectrum disorder in Western China impacts employment and increases financial burden in women

in Multiple Sclerosis and Neuroimmunology

Lin Han
Peiwei Hong
Yang Wan
Linjun Cai
Ziyan Shi
Jiancheng Wang
YanLin Lang
Hongyu Zhou

Frontiers in Neurology

doi 10.3389/fneur.2022.973163

1,872 views
3 citations

Original Research

Published on 08 Sep 2022

Early predictors of visual and axonal outcomes after acute optic neuritis

in Multiple Sclerosis and Neuroimmunology

Minh N. L. Nguyen
Chao Zhu
Scott C. Kolbe
Helmut Butzkueven
Owen B. White
Joanne Fielding
Trevor J. Kilpatrick
Gary F. Egan
Alexander Klistorner
Anneke van der Walt

Frontiers in Neurology

doi 10.3389/fneur.2022.945034

2,242 views
5 citations

Original Research

Published on 06 Sep 2022

The patient journey with NMOSD: From initial diagnosis to chronic condition

in Multiple Sclerosis and Neuroimmunology

Guillermo Delgado-Garcia
Sheryl Lapidus
Rosa Talero
Michael Levy

Frontiers in Neurology

doi 10.3389/fneur.2022.966428

9,756 views
12 citations

Opinion

Published on 01 Sep 2022

Time to rethink the reported disease-modifying treatment effects on cognitive outcomes: Methods and interpretative caveats

in Multiple Sclerosis and Neuroimmunology

Andrés Labiano-Fontcuberta
Enric Monreal
Julián Benito-León

Frontiers in Neurology

doi 10.3389/fneur.2022.995690

1,773 views
7 citations

Original Research

Published on 01 Sep 2022

Elevated ApoB/ApoA-I ratio is associated with acute anti-N-Methyl-D-aspartate receptor encephalitis, but not disease outcomes

in Multiple Sclerosis and Neuroimmunology

Yingying Liu
Xiaomeng Ma
Lili Ma
Zhumin Su
Donghong Li
Xiaohong Chen

Frontiers in Neurology

doi 10.3389/fneur.2022.896656

1,540 views
3 citations

Opinion

Published on 01 Sep 2022

Autoantibodies in post-treatment Lyme disease syndrome

in Multiple Sclerosis and Neuroimmunology

Armin Alaedini
Gary P. Wormser

Frontiers in Neurology

doi 10.3389/fneur.2022.1004853

1,930 views

Editorial

Published on 30 Aug 2022

Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications

in Multiple Sclerosis and Neuroimmunology

Aurora Zanghì
Carlo Avolio
Hans-Peter Hartung
Emanuele D'Amico

Frontiers in Neurology

doi 10.3389/fneur.2022.996342

1,871 views
2 citations

Original Research

Published on 29 Aug 2022

Somatosensory evoked potentials and their relation to microstructural damage in patients with multiple sclerosis—A whole brain DTI study

in Multiple Sclerosis and Neuroimmunology

Jan Hamann
Barbara Ettrich
Karl Titus Hoffman
Florian Then Bergh
Donald Lobsien

Frontiers in Neurology

doi 10.3389/fneur.2022.890841

3,538 views

Original Research

Published on 29 Aug 2022

The use of functional near infrared spectroscopy and gait analysis to characterize cognitive and motor processing in early-stage patients with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Maria Adelia de Aratanha
Joana Bisol Balardin
Carolina Cardoso do Amaral
Shirley S. Lacerda
Tiago Abrão Setrak Sowmy
Theodore J. Huppert
Rodrigo Barbosa Thomaz
Danielli S. Speciali
Birajara Machado
Elisa Harumi Kozasa

Frontiers in Neurology

doi 10.3389/fneur.2022.937231

3,196 views
7 citations

Case Report

Published on 29 Aug 2022

Anti-γ-aminobutyric acid-A receptor encephalitis with refractory seizures and cognitive impairment in a young woman: A case report

in Multiple Sclerosis and Neuroimmunology

Xue Yang
Bo Deng
Shengjun Wang
Xiaotang Wang
Lili Cao
Xiangjun Chen
Xiuhe Zhao

Frontiers in Neurology

doi 10.3389/fneur.2022.954494

2,569 views
2 citations